In 2019, Shen et al. demonstrated an aberrant expression of POTEE, another paralog of POTE gene family, perturbed the SPHK1/p65 signalling axis that consequently promoted tumorigenesis by inhibiting apoptosis in CRC cells. This evidence concerns the gene POTED and colorectal carcinoma.